One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
A watershed moment for the BJD: Authors retain their article copyright
John R Ingram
doi : 10.1093/bjd/ljac006
The promise of personalized medicine for hidradenitis suppurativa
Martin M Okun
doi : 10.1093/bjd/ljac033
Deficiencies in mismatch DNA repair: providing the soil for large-to-giant congenital melanocytic naevus development
Mitchell S Stark
doi : 10.1093/bjd/ljac037
Does bimekizumab stand the test of time for psoriasis?
Sara Mirali, Jensen Yeung
doi : 10.1093/bjd/ljac052
Down expressed in keloid (DEIK): a new player in the pathogenesis of keloids
Sepideh Hamzehlou, Donald Alexander Glass, 2nd
doi : 10.1093/bjd/ljac056
Identification of the underlying gene for Flegel disease: another ‘two-hit’ genodermatosis?
Huijun Wang, Zhimiao Lin
doi : 10.1093/bjd/ljac063
Adding up the desmosomal genes causing syndromes with hair and skin involvement: identification of TUFT1 by state-of-the-art whole-genome sequencing
Judith Fischer, Svenja Alter
doi : 10.1093/bjd/ljac073
The devastating impact of hidradenitis suppurativa on employment
Niamh Kearney, Brian Kirby
doi : 10.1093/bjd/ljac079
EASE-y does it: Oleogel-S10 for epidermolysis bullosa wounds
Jemima E Mellerio
doi : 10.1093/bjd/ljac034
Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study
Johannes S Kern, Eli Sprecher, Maria Florencia Fernandez, Franziska Schauer, Christine Bodemer, Tracy Cunningham, Sandra Löwe, Charles Davis, Mark Sumeray, Anna L Bruckner, Dédée F Murrell, for the EASE investigators
doi : 10.1093/bjd/ljac001
Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial
Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial
doi : 10.1093/bjd/ljac021
Association of metformin use and survival in patients with cutaneous melanoma and diabetes
Isabelle Krakowski, Henrike Häbel, Kari Nielsen, Christian Ingvar, Therese M L Andersson, Ada Girnita, Karin E Smedby, Hanna Eriksson
doi : 10.1093/bjd/ljac003
Pain experiences among those living with hidradenitis suppurativa: a qualitative study
Lauren A V Orenstein, Nicole Salame, Meron R Siira, Megan Urbanski, Nyla I Flowers, Harika Echuri, Amit Garg, Anne Marie McKenzie-Brown, Kimberly A Curseen, Rachel E Patzer, Dio Kavalieratos, Suephy C Chen
doi : 10.1093/bjd/ljac018
B-cell and complement signature in severe hidradenitis suppurativa that does not respond to adalimumab
Roisin Hambly, Solene Gatault, Conor M Smith, Luis F Iglesias-Martinez, Sean Kearns, Helen Rea, Vivien Marasigan, Kate Lynam-Loane, Shivashini Kirthi, Rosalind Hughes, Jean M Fletcher, Walter Kolch, Brian Kirby
doi : 10.1093/bjd/ljac007
Deficient mismatch repair is detected in large-to-giant congenital melanocytic naevi: providing new insight into aetiology and diagnosis
Boxuan Wei, Jieyu Gu, Bowen Gao, Yongyang Bao, Ran Duan, Qingfeng Li, Feng Xie
doi : 10.1093/bjd/ljac020
Biallelic TUFT1 variants cause woolly hair, superficial skin fragility and desmosomal defects
Adam Jackson, Celia Moss, Kate E Chandler, Pablo Lopez Balboa, Maria L Bageta, Gabriela Petrof, Anna E Martinez, Lu Liu, Alyson Guy, Jemima E Mellerio, John Y W Lee, Malobi Ogboli, Gavin Ryan, Genomics England Research Consortium, John A McGrath, Siddharth Banka
doi : 10.1093/bjd/ljac026
Risk single-nucleotide polymorphism-mediated enhancer–promoter interaction drives keloids through long noncoding RNA down expressed in keloids
Cheng-Cheng Deng, Li-Xue Zhang, Xue-Yan Xu, Ding-Heng Zhu, Qing Cheng, Shufeng Ma, Zhili Rong, Bin Yang
doi : 10.1093/bjd/ljac025
Pathogenic variants in the SPTLC1 gene cause hyperkeratosis lenticularis perstans
Sabine Jägle, Hao-Hsiang Hsu, Hazem A Juratli, Andreas D Zimmer, Amelie Prieschl, Svenja Alter, Bernhard Wiedenhofer, Dieter Metze, Steffen Emmert, Judith Fischer
doi : 10.1093/bjd/ljac019
Variants in KLK11, affecting signal peptide cleavage of kallikrein-related peptidase 11, cause an autosomal-dominant cornification disorder
Zhuoqing Gong, Shangzhi Dai, Xingyuan Jiang, Mingyang Lee, Xuejun Zhu, Huijun Wang, Zhimiao Lin
doi : 10.1093/bjd/ljac029
Impact of response patterns for patients with advanced acral melanoma treated with anti-programmed death-1 monotherapy
Li Zhou, Lizhi Shao, Shunyu Gao, Chuanliang Cui, Zhihong Chi, Xinan Sheng, Bixia Tang, Lili Mao, Bin Lian, Xieqiao Yan, Xuan Wang, Xue Bai, Siming Li, Jun Guo, Lu Si
doi : 10.1093/bjd/ljac005
The impact of hidradenitis suppurativa on professional life
Sylke Schneider-Burrus, Stefanie Kalus, Björn Fritz, Kerstin Wolk, Susana Gomis-Kleindienst, Robert Sabat
doi : 10.1093/bjd/ljac027
Improving migrant health in the USA: opportunities for dermatologists to participate in care delivery, asylum medicine and community partnership
Penelope Kim-Lim, Herbert Castillo Valladares, Alexia Knapp, Coleen Kivlahan, Aileen Y Chang
doi : 10.1093/bjd/ljac011
Planetary health in dermatology: towards a sustainable concept of health in clinical practice guidelines
Ruben Heuer, Matthew Gaskins, Ricardo N Werner, Alexander Nast, Susanne Saha
doi : 10.1093/bjd/ljac022
Patient perspectives on the lived experience of granuloma annulare
Abigale Clark, Michael J Murphy, Brett King, Jeffrey M Cohen, Misha Rosenbach, John Barbieri, William Damsky
doi : 10.1093/bjd/ljac004
The perspectives of 606 US dermatologists on active surveillance for low-risk basal cell carcinoma
Sven van Egmond, Isabella de Vere Hunt, Zhuo Ran Cai, Nada Rizk, Marlies Wakkee, Mary-Margaret Chren, Noah Goldfarb, Julia F Simard, Eleni Linos
doi : 10.1093/bjd/ljac002
Semi-virtual patch testing: the future?
Rosie Vincent, Emma Ormerod, Charlotte E Gollins, Nabina Rai, Karen Conduit-Turner, Aparna Sinha, Jane Sansom
doi : 10.1093/bjd/ljac013
Birth incidence and outcome of harlequin ichthyosis and collodion membrane in the UK and Ireland: a national 2-year prospective surveillance study
Celia Moss, Fozia Roked, Peter J Davis, Murtaza Khan, Catherine Tyler, Samantha Ibbs, Andrew K Ewer
doi : 10.1093/bjd/ljac015
The top 10 research priorities for skin cancer surgery in the UK: results of a James Lind Alliance Priority Setting Partnership
Alistair C Brown, Eleanor M Earp, David Veitch, Aaron Wernham, Surgical Priority Setting Partnership Steering Group
doi : 10.1093/bjd/ljac014
Bacillus Calmette–Guérin-induced lupus vulgaris in a patient with Mendelian susceptibility to mycobacterial disease caused by a novel STAT1 variation
Aika Shionoya, Yuko Yoto, Tokimasa Hida, Aki Ishikawa, Tadashi Hasegawa, Takeshi Tsugawa, Hisashi Uhara
doi : 10.1093/bjd/ljac009
Burden of disease: assessing quality-of-life impacts in hyperhidrosis
Michaela Gabes, Theresa Donhauser, Gesina Kann, Clarissa Masur, Christian Apfelbacher
doi : 10.1093/bjd/ljac010
Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced cutaneous T-cell lymphoma
Mathias Oymanns, Michael Daum-Marzian, Aliyah Bellm, Khaled Elsayad, Hans T Eich, Chalid Assaf
doi : 10.1093/bjd/ljac012
Interleukin-13 inhibition by tralokinumab reduces inducible T-cell costimulator-positive innate lymphoid cells in skin lesions of atopic dermatitis
Toshiaki Kogame, Satoru Yonekura, Paola Lovato, Masahiro Hirata, Riko Takimoto-ito, Tomoya Takegami, Takayoshi Komatsu-Fujii, Naotomo Kambe, Takashi Nomura, Mads A Røpke, Kenji Kabashima
doi : 10.1093/bjd/ljac008
Pigmented demodicosis presenting as lentigo maligna diagnosed by reflectance confocal microscopy
Clemence Bertold, Philippe Martel, Thierry Passeron, Philippe Bahadoran
doi : 10.1093/bjd/ljac023
Biologic tapering for patients with psoriasis with low disease activity: data from the French PsoBioTeq Registry
Helene Aubert, Hugo Arlegui, Yann De Rycke, Herve Bachelez, Marie Beylot-Barry, Alain Dupuy, Pascal Joly, Denis Jullien, Emmanuel Mahé, Carle Paul, Marie-Aleth Richard, Emilie Sbidian, Manuelle Viguier, Olivier Chosidow, Florence Tubach, Nathalie Bénéton, for the PsoBioTeq Study Group
doi : 10.1093/bjd/ljac024
Vascular endothelial growth factor, tissue factor, coagulation and fibrinolysis markers in slow-flow vascular malformations: a prospective study of treatment with sirolimus
Annabel Maruani, Anne-Guillemette Moineau, Olivia Boccara, Juliette Mazereeuw-Hautier, Sophie Leducq, Didier Bessis, Laurent Guibaud, Pierre Vabres, Stephanie Mallet, Sebastien Barbarot, Christine Chiaverini, Catherine Droitcourt, Anne-Claire Bursztejn, Céline Lengelle, Jean-Baptiste Woillard, Denis Herbreteau, Anne Le Touze, Aurélien Binet, Baptiste Morel, Hélène Bourgoin, Valérie Gissot, Bruno Giraudeau, Yves Gruel, Elsa Tavernier, Jérôme Rollin on behalf of the Groupe de Recherche de la Société Française de Dermatologie Pédiatrique
doi : 10.1093/bjd/ljac028
Water and adult eczema: the hard truth?
Junfen Zhang, Marie L A Schuttelaar
doi : 10.1093/bjd/ljac032
When too much is too much: noncoding duplications in skin disorders
Verónica Yumiceba, Malte Spielmann
doi : 10.1093/bjd/ljac030
Clinical trial of Oleogel-S10 (birch bark extract gel) in epidermolysis bullosa
doi : 10.1093/bjd/ljac156
Providing new insights into the causes of large-to-giant congenital melanocytic naevi
doi : 10.1093/bjd/ljac167
